- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/14 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 231/14
Total number of patents in this class: 1166
10-year publication summary
|
71
|
93
|
79
|
71
|
76
|
79
|
66
|
54
|
48
|
35
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Cropscience AG | 1846 |
58 |
| Theravance Biopharma R&D IP, LLC | 407 |
48 |
| BASF SE | 21303 |
35 |
| Syngenta Participations AG | 1527 |
34 |
| Syngenta Crop Protection AG | 6699 |
33 |
| BioCryst Pharmaceuticals, Inc. | 182 |
31 |
| Orion Corporation | 770 |
19 |
| Takeda Pharmaceutical Company Limited | 2715 |
18 |
| Sumitomo Chemical Company, Limited | 8996 |
15 |
| Activesite Pharmaceuticals, Inc. | 18 |
15 |
| Loxo Oncology, Inc. | 84 |
12 |
| Solvay SA | 945 |
12 |
| Syngenta Limited | 427 |
11 |
| Dow AgroSciences LLC | 1188 |
11 |
| Research Triangle Institute | 418 |
11 |
| sanofi-aventis | 302 |
11 |
| Hoffmann-La Roche Inc. | 3783 |
10 |
| AstraZeneca AB | 2818 |
10 |
| Bayer Intellectual Property GmbH | 2379 |
10 |
| Rezolute, Inc. | 33 |
10 |
| Other owners | 752 |